The pharma industry’s global reach and scale is unparalleled. What’s at stake here isn’t just corporate profitability, but access to trials to improve the quality and duration of life for patients desperately in search of new cures.
If Pharma Companies Don’t Overhaul Their R&D Model Quickly, Cancer Patients In Desperate Search For New Cures Will Be Left Behind
